The real-time, digital, and end-point PCR markets are projected to decline at a compound annual growth rate (CAGR) of 8.2 percent between 2019 and 2029.The market for these technologies was anticipated to generate USD 31.64 billion in 2021. It is anticipated that the fall in demand for PCR testing for COVID-19 testing would impede market expansion. The global market for real-time PCR (qPCR), digital PCR (dPCR), and end-point PCR is anticipated to expand at a compound annual growth (CAGR) of 7.8 per cent from 2019 to 2029 notwithstanding the absence of the COVID-19 pandemic.
Covid-19 Impact & Market Status
Due to the growth of COVID-19 cases throughout the world and the desire for effective and quick testing, the demand for these kits has skyrocketed. The method that is most in demand in the healthcare market is the RT-PCR kit.
This factor is important since it is causing the real-time PCR (qPCR) market to grow. Real-time PCR (qPCR) devices, one of the most accurate laboratory methods for monitoring, detecting, and investigating the coronavirus, are being kindly provided by a number of research organisations and universities.
In 2021, the clinical category's sales share peaked at more than 85.0 percent. This can be attributed to a number of things, such as the rising prevalence of diseases like cancer, infectious diseases, and diabetes, high evaluation precision, the growing commercialization of screening reagents, effective disease diagnosis, tracking, and diagnosis, and outline in disease detection. Thermo Fisher Scientific Inc. introduced The QuantStudio 6 & 7 Pro RT-PCR Systems in April 2019 as one illustration. Other functions offered by these systems include voice assistance, facial recognition, and RF identification. In a similar manner, QIAGEN announced in January 2019 the introduction of a new line of digital polymerase chain reaction equipment. It provides more automated processes in comparison to standard digital PCR technology.
Over the course of the forecast, the forensic category is expected to increase at the quickest rate. The increasing use of cutting-edge methods in forensic applications, such as DNA testing, genetic markers, and DNA typing, is expected to drive the segment throughout the predicted time period. Another element boosting the market is the advancement of modern technologies, which are creating a library of durable materials for forensic DNA typing.
Over the course of the forecast, the forensic category is expected to increase at the quickest rate. The increasing use of cutting-edge methods in forensic applications, such as DNA testing, genetic markers, and DNA typing, is expected to drive the segment throughout the predicted time period. Another element boosting the market is the advancement of modern technologies, which are creating a library of durable materials for forensic DNA typing. The forensic category is anticipated to grow at the fastest pace over the period. The increasing use of cutting-edge methods in forensic applications, such as DNA testing, genetic markers, and DNA typing, is expected to drive the segment throughout the predicted time period. Another element boosting the market is the advancement of modern technologies, which are creating a library of durable materials for forensic DNA typing.
Consumables and reagents had the biggest revenue share (more than 60.0 percent) in 2021. The COVID-19 pandemic outbreak, the increase in demand for early sickness detection, and the sheer number of major enterprises generating digital PCR consumables and reagents may all be attributed to this. The widespread usage of consumables and reagents, as well as the rising demand for healthcare, research, and other uses, all contribute to the large segment share. The sector is also projected to maintain its top position during the projection period.
The increased frequency of chronic illnesses and the growing use of PCR have also increased the need for consumables and reagents. Additionally, during the anticipated decade, this market would have a significant amount of potential due to the increased use of technical advancements in the pharmaceutical and healthcare sectors as well as improved research and development.
The quantitative PCR segment had the highest revenue share in 2021, at around 85.0 percent. Point-of-care diagnostics, the increasing need for automated systems, and rapid technological advancement are some of the factors propelling this market segment. The market has expanded exponentially as a result of the growing use of technology and the introduction of real-time PCR-based COVID-19 screening and diagnosis solutions. For instance, in March 2020, Bruker Corporation and a Novacyt SA subsidiary signed a partnership for the distribution of the genesig real-time PCR coronavirus test in the US, UK, Spain, France, and Germany.
With the use of primers, the polymerase enzyme, and several heating cycles, PCR may create an endless number of copies of DNA from a single strand. Cross-contamination is less likely to happen because these tests are carried out in automated thermal cyclers. The demand for molecular testing is rising as technology develops. DPCR and qPCR are typical diagnostic techniques used in the pharmaceutical, biotech, and research fields. They have a wide range of applications.
The healthcare sector has been greatly impacted by the COVID-19 epidemic. The market's exponential growth had the greatest negative influence on the diagnostic sector. Digital PCR and real-time PCR have drawn a lot of interest because of their use in drug development and diagnostics. Players in the market are working harder to develop droplet digital PCR kits to find COVID-19. For COVID-19 testing, several market participants have also developed whole new tests and instruments. For instance, the Bio-Rad SARS-CoV-2 ddPCR Kit was given Emergency Use Authorization (EUA) by the U.S. FDA in September 2020 for the purpose of detecting SARS-CoV-2 infection. The following actions have received the unwavering support of regulatory organisations in an effort to lessen the effects of the COVID-19 epidemic:
To curb the spread and boost sales, several businesses have altered their marketing plans. Major market companies are focusing on cutting-edge technology to progress the sector.
The advancement of the use of biomarker profiling for disease diagnosis, the finalisation of the Human Genome Project, the rise in prevalence of genetic problems, and severe infectious diseases will all contribute to an increase in demand for technically advanced PCR tests over the projection period. As a consequence of major technological advancements, increasing investments, financing, and grants in a range of applications, it is projected that the need for digital PCR will rise over the next years.
Demands from consumers for early disease identification and treatment have driven genetic research, the growth of genetic technology, and the production of novel genetic goods. This growth in R&D activities is being supported by more money and awards being offered, as well as more investment. Governments and federal organisations all around the world are also emphasising the use of qPCR and dPCR technologies in genomics research. The genomic research in the qPCR and dPCR sectors has been sponsored over the past 10 years by a variety of financing initiatives from governmental and business agencies.
The major players of the global Real Time PCR (QPCR) market are Thermofischer Scientific Inc., Bio-Rad Laboratories Inc., Agilent Technologies, Inc., BIOTECON Diagnostics, Sigma-Aldrich Co. LLC., Takara Bio Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, QIAGEN N.V.
Latest Innovations in the Global Real Time PCR (QPCR) Market: a Snapshot
- As qPCR techniques are used more often in drug development and other research activities, there will be a growth in real-time PCR (qPCR) products in the biotechnology and pharmaceutical industries.
- As more biotechnology and pharmaceutical firms concentrate on the use of cutting-edge techniques for the diagnosis of various illnesses, the real-time PCR (qPCR) market is also projected to grow.
- The current COVID-19 epidemic, which has already affected the whole world, will also likely have an effect on the market. In addition, initiatives like the Indian government's licencing of 12 quick antibody test kits for COVID-19 diagnosis have significantly boosted the real-time PCR (qPCR) business.
Real Time PCR ( QPCR) Market Scope
|Forecast Unit||Value (USD)|
|Revenue forecast in 2028||USD 31.64 billion|
|Growth Rate||CAGR of 8.2 % during 2021-2028|
|Segment Covered||Type, Application, Downstream Fields, Regions|
|Regions Covered||North America, Europe, Asia Pacific, Middle East and Africa, South America|
|Key Players Profiled||Thermofischer Scientific Inc., Bio-Rad Laboratories Inc., Agilent Technologies, Inc., BIOTECON Diagnostics, Sigma-Aldrich Co. LLC., Takara Bio Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, QIAGEN N.V.|
Key Segments of the Global Real Time PCR (QPCR) Market
Type Overview, 2019-2029 (USD Billion)
- Real-Time PCR (qPCR) Systems
- Reagents and Assays
- Real-Time PCR (qPCR) Consumables
- PCR Primers, Assays, and Arrays
- PCR Plates, Seals & Tubes
Application Overview, 2019-2029 (USD Billion)
Downstream Fields Overview, 2019-2029 (USD Billion)
- Diagnostic Laboratories
- Academic and Research Institutes
- Biopharmaceutical Companies
- Contract Research Organizations
- Animal Health
- Food & Agriculture Industries
Regional Overview, 2019-2029 (USD Billion)
- Rest of Europe
- Rest of Asia Pacific
- Rest of South America
Middle East and South Africa